Mechanism of impairment on liver regeneration in elderly patients: Role of hepatic stellate cell function

Hepatology Research

Volumn 47, Issue 6, 2017, Pages 505-513

  Saito, Yu ^a   Morine, Yuji ^a   Shimada, Mitsuo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

hepatic stellate cells; impairment on liver regeneration; senescence

Indexed keywords

AGED; CANCER SURGERY; CELL AGING; CELL FUNCTION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FIBROGENESIS; HEPATIC STELLATE CELL; HUMAN; IMMUNOCOMPETENT CELL; KUPFFER CELL; LIVER CELL; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER REGENERATION; LIVER RESECTION; NONHUMAN; REVIEW; SENESCENCE;

EID: 85017372789     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12872     Document Type: Review

References (78)

1. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365: 1118–1127.
2. Tsujita E, Utsunomiya T, Ohta M et al. Outcome of repeat hepatectomy in patients with hepatocellular carcinoma aged 75 years and older. Surgery 2010; 147: 696–703.
3. Nanashima A, Abo T, Nonaka T et al. Prognosis of patients with hepatocellular carcinoma after hepatic resection: are elderly patients suitable for surgery? J Surg Oncol 2011; 104: 284–291.
4. Takenaka K, Shimada M, Higashi H et al. Liver resection for hepatocellular carcinoma in the elderly. Arch Surg 1994; 129: 846–850.
5. Yamamoto K, Takenaka K, Matsumata T et al. Right hepatic lobectomy in elderly patients with hepatocellular carcinoma. Hepatogastroenterology 1997; 44: 514–518.
6. Poon RT, Fan ST, Lo CM et al. Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol 1999; 94: 2460–2466.
7. Wu CC, Chen JT, Ho WL et al. Liver resection for hepatocellular carcinoma in octogenarians. Surgery 1999; 125: 332–338.
8. Hanazaki K, Kajikawa S, Shimozawa N et al. Hepatic resection for hepatocellular carcinoma in the elderly. J Am Coll Surg 2001; 192: 38–46.
9. Yeh CN, Lee WC, Jeng LB, Chen MF. Hepatic resection for hepatocellular carcinoma in elderly patients. Hepatogastroenterology 2004; 51: 219–223.
10. Ferrero A, Viganò L, Polastri R et al. Hepatectomy as treatment of choice for hepatocellular carcinoma in elderly cirrhotic patients. World J Surg 2005; 29: 1101–1105.
11. Zhou L, Rui JA, Wang SB et al. Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma. Eur J Surg Oncol 2006; 32: 767–772.
12. Kondo K, Chijiiwa K, Funagayama M, Kai M, Otani K, Ohuchida J. Hepatic resection is justified for elderly patients with hepatocellular carcinoma. World J Surg 2008; 32: 2223–2229.
13. Kaibori M, Matsui K, Ishizaki M et al. Hepatic resection for hepatocellular carcinoma in the elderly. J Surg Oncol 2009; 99: 154–160.
14. Oishi K, Itamoto T, Kobayashi T et al. Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more. J Gastrointest Surg 2009; 13: 695–701.
15. Huang J, Li BK, Chen GH et al. Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy. J Gastrointest Surg 2009; 13: 1627–1635.
16. Mirici-Cappa F, Gramenzi A, Santi V et al. Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience. Gut 2010; 59: 387–396.
17. Portolani N, Baiocchi GL, Coniglio A et al. Limited liver resection: a good indication for the treatment of hepatocellular carcinoma in elderly patients. Jpn J Clin Oncol 2011; 41: 1358–1365.
18. Yamada S, Shimada M, Miyake H et al. Outcome of hepatectomy in super-elderly patients with hepatocellular carcinoma. Hepatol Res 2012; 42: 454–458.
19. Tsujita E, Utsunomiya T, Yamashita Y et al. Outcome of hepatectomy in hepatocellular carcinoma patients aged 80 years and older. Hepatogastroenterology 2012; 59: 1553–1555.
20. Nishikawa H, Arimoto A, Wakasa T, Kita R, Kimura T, Osaki Y. Surgical resection for hepatocellular carcinoma: clinical outcomes and safety in elderly patients. Eur J Gastroenterol Hepatol 2013; 25: 912–919.
21. Hirokawa F, Hayashi M, Miyamoto Y et al. Surgical outcomes and clinical characteristics of elderly patients undergoing curative hepatectomy for hepatocellular carcinoma. J Gastrointest Surg 2013; 17: 1929–1937.
22. Ide T, Miyoshi A, Kitahara K, Noshiro H. Prediction of postoperative complications in elderly patients with hepatocellular carcinoma. J Surg Res 2013; 185: 614–619.
23. Ueno M, Hayami S, Tani M, Kawai M, Hirono S, Yamaue H. Recent trends in hepatectomy for elderly patients with hepatocellular carcinoma. Surg Today 2014; 44: 1651–1659.
24. Taniai N, Yoshida H, Yoshioka M, Kawano Y, Uchida E. Surgical outcomes and prognostic factors in elderly patients (75 years or older) with hepatocellular carcinoma who underwent hepatectomy. J Nippon Med Sch 2013; 80: 426–432.
25. Wang WL, Zhu Y, Cheng JW et al. Major hepatectomy is safe for hepatocellular carcinoma in elderly patients with cirrhosis. Eur J Gastroenterol Hepatol 2014; 26: 444–451.
26. Zhu C, Ikemoto T, Utsunomiya T et al. Senescence-related genes possibly responsible for poor liver regeneration after hepatectomy in elderly patients. J Gastroenterol Hepatol 2014; 29: 1102–1108.
27. Akamatsu N, Sugawara Y, Tamura S et al. Impact of live donor age on liver transplantation. Transplant Proc 2007; 39: 3189–3193.
28. Hirata M, Harihara Y, Kitamura T et al. The influence of donor age to graft volume increase rate in living donor liver transplantation. Transplant Proc 2001; 33: 1416–1417.
29. Ikegami T, Nishizaki T, Yanaga K et al. The impact of donor age on living donor liver transplantation. Transplantation 2000; 70: 1703–1707.
30. Iwamoto T, Yagi T, Umeda Y et al. The impact of donor age on the outcome of adult living donor liver transplantation. Transplantation 2008; 85: 1240–1245.
31. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006; 43: 45–53.
32. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007; 231: 286–300.
33. Sharpless NE. Ink4a/Arf links senescence and aging. Exp Gerontol 2004; 39: 1751–1759.
34. Enkhbold C, Morine Y, Utsunomiya T et al. Dysfunction of liver regeneration in aged liver after partial hepatectomy. J Gastroenterol Hepatol 2015; 30: 1217–1224.
35. Nejak-Bowen K, Orr A, Bowen WC Jr, Michalopoulos GK. Conditional genetic elimination of hepatocyte growth factor in mice compromises liver regeneration after partial hepatectomy. PLoS One 2013; 8: e59836.
36. Chen JH, Hales CN, Ozanne SE. DNA damage, cellular senescence and organismal ageing: causal or correlative? Nucleic Acids Res 2007; 35: 7417–7428.
37. Jeyapalan JC, Sedivy JM. Cellular senescence and organismal aging. Mech Ageing Dev 2008; 129: 467–474.
38. Fujita T, Uchida K, Maruyama N. Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim Biophys Acta 1992; 1116: 122–128.
39. Gil J, Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 2006; 7: 667–677.
40. Galehdar Z, Swan P, Fuerth B, Callaghan SM, Park DS, Cregan SP. Neuronal apoptosis induced by endoplasmic reticulum stress is regulated by ATF4-CHOP-mediated induction of the Bcl-2 homology 3-only member PUMA. J Neurosci 2010; 30: 16938–16948.
41. Chandra D, Bratton SB, Person MD et al. Intracellular nucleodites act as critical prosurvival factors by binding to cytochrome C and inhibiting apoptosome. Cell 2006; 125: 1333–1346.
42. Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, Vandenabeele P. Toxic proteins released from mitochondria in cell death. Oncogene 2004; 23: 2861–2874.
43. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003; 4: 552–565.
44. Enari M, Sakahira H, Yokohama H, Okawa K, Iwamatsu A, Nagata S. A caspase activated DNAse when released from mitochondria. Nature 1998; 391: 43–50.
45. Haga S, Terui K, Fukai M et al. Preventing hypoxia/reoxygenation damage to hepatocytes by p66(shc) ablation: up-regulation of anti-oxidant and anti-apoptotic proteins. J Hepatol 2008; 48: 422–432.
46. Migliaccio E, Giorgio M, Mele S et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999; 402: 309–313.
47. Nemoto S, Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 2002; 295: 2450–2452.
48. Blaner WS, O'Byrne SM, Wongsiriroj N et al. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim Biophys Acta 2009; 1791: 467–473.
49. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008; 88: 125–172.
50. Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 2011; 25: 195–206.
51. Ellis EL, Mann DA. Clinical evidence for the regression of liver fibrosis. J Hepatol 2012; 56: 1171–1180.
52. Kisseleva T, Cong M, Paik Y et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci USA 2012; 109: 9448–9453.
53. Troeger JS, Mederacke I, Gwak GY et al. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 2012; 143: 1073–1083 e1022.
54. Krizhanovsky V, Yon M, Dickins RA et al. Senescence of activated stellate cells limits liver fibrosis. Cell 2008; 134: 657–667.
55. Roskams T. Relationships among stellate cell activation, progenitor cells, and hepatic regeneration. Clin Liver Dis 2008; 12: 853–860.
56. Yang L, Jung Y, Omenetti A et al. Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells 2008; 26: 2104–2113.
57. Kordes C, Sawitza I, Götze S et al. Hepatic stellate cells contribute to progenitor cells and liver regeneration. J Clin Invest 2014 Dec; 124: 5503–5515.
58. Shen K, Chang W, Gao X et al. Depletion of activated hepatic stellate cell correlates with severe liver damage and abnormal liver regeneration in acetaminophen-induced liver injury. Acta Biochim Biophys Sin (Shanghai) 2011; 43: 307–315.
59. Kalinichenko VV, Bhattacharyya D, Zhou Y et al. Foxf1+/− mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury. Hepatology 2003; 37: 107–117.
60. Bonacchi A, Petrai I, Defranco RM et al. The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology 2003; 125: 1060–1076.
61. Unanue ER. Ito cells, stellate cells, myofibroblasts: new actors in antigen presentation. Immunity 2007; 26: 9–10.
62. Maher JJ, Lozier JS, Scott MK. Rat hepatic stellate cells produce cytokine-induced neutrophil chemoattractant in culture and in vivo. Am J Physiol Gastrointest Liver Physiol 1998; 275: G847–G853.
63. Chen L, Zhang W, Zhou Q et al. HSCs play a distinct role in different phases of oval cell-mediated liver regeneration. Cell Biochem Funct 2012; 30: 588–596.
64. Passino MA, Adams RA, Sikorski SL, Akassoglou K. Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR. Science 2007; 315(5820): 1853–1856.
65. Pi L, Ding X, Jorgensen M et al. Connective tissue growth factor with a novel fibronectin binding site promotes cell adhesion and migration during rat oval cell activation. Hepatology 2008; 47: 996–1004.
66. Schuppan D, Schmid M, Somasundaram R et al. Collagens in the liver extracellular matrix bind hepatocyte growth factor. Gastroenterology 1998; 114: 139–152.
67. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004; 5: 836–847.
68. Karkampouna S, Ten Dijke P, Dooley S, Julio MK. TGFbeta Signaling in Liver Regeneration. Curr Pharm Des 2012; 18(27): 4103–4113.
69. Ebrahimkhani MR, Oakley F, Murphy LB et al. Stimulating healthy tissue regeneration by targeting the 5-HT(2)B receptor in chronic liver disease. Nat Med 2011; 17: 1668–1673.
70. Vollmar B, Pradarutti S, Richter S, Menger MD. In vivo quantification of ageing changes in the rat liver from early juvenile to senescent life. Liver 2002; 22: 330–341.
71. Schmucker DL. Age-related changes in liver structure and function: Implications for disease? Exp Gerontol 2005; 40: 650–659.
72. Warren A, Cogger VC, Fraser R, DeLeve LD, McCuskey RS, LeCouteur DG. The effects of old age on hepatic stellate cells. Curr Gerontol Geriatr Res 2011; 2011: 439835.
73. Enzan H, Saibara T, Ueda H et al. Ultrastructural observation of Ito cells in the aged rats. In: Wisse E, Knook DL, McCuskey RS, eds. Cells of the Hepatic Sinusoid: LeidenKupffer Cell Foundation, 1991; 226–229.
74. Grizzi F, Franceschini B, Gagliano N et al. Mast cell density, hepatic stellate cell activation and TGF-β transcripts in the aging Sprague–Dawley rat during early acute liver injury. Toxicol Pathol 2003; 31: 173–178.
75. Marcos R, Correia-Gomes C. Long live the liver: immunohistochemical and stereological study of hepatocytes, liver sinusoidal endothelial cells, Kupffer cells and hepatic stellate cells of male and female rats throughout ageing. Cell Tissue Res 2016; 366: 639–649.
76. Reid LM, Fiorino AS, Sigal SH, Brill S, Holst PA. Extracellular matrix gradients in the space of Disse: relevance to liver biology. Hepatology 1992; 15: 1198–1203.
77. Senoo H, Yoshikawa K, Morii M, Miura M, Imai K, Mezaki Y. Hepatic stellate cell (vitamin A-storing cell) and its relative – past, present and future. Cell Biol Int 2010; 34: 1247–1272.
78. Yang C, Zeisberg M, Mosterman B et al. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 2013; 124: 147–159.